Catecholamine use is associated with enterocyte damage in critically ill patients

Shock

Volumn 43, Issue 5, 2015, Pages 437-442

  Piton, Gaël ^a,b   Cypriani, Benoit ^a   Regnard, Jacques ^a,b   Patry, Cyrille ^a   Puyraveau, Marc ^a   Capellier, Gilles ^a,b,c  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c School of Public Health and Preventive Medicine   (Australia)

Author keywords

Catecholamine; intestinal fatty acid binding protein; shock

Indexed keywords

ADRENALIN; CATECHOLAMINE; CITRULLINE; DOBUTAMINE; FATTY ACID BINDING PROTEIN; NORADRENALIN;

ABDOMINAL PRESSURE; ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CARDIOGENIC SHOCK; CELL DAMAGE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HEART ARREST; HEMORRHAGIC SHOCK; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTESTINE CELL; INTOXICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC DISORDER; MIDDLE AGED; MORTALITY; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PERFUSION PRESSURE; PROGNOSIS; PROSPECTIVE STUDY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SMALL INTESTINE DISEASE; BLOOD; BLOOD FLOW VELOCITY; CRITICAL ILLNESS; DRUG EFFECTS; HEMODYNAMICS; INTENSIVE CARE; ODDS RATIO; PATHOLOGY; PATHOPHYSIOLOGY; SMALL INTESTINE;

AGED; BLOOD FLOW VELOCITY; CATECHOLAMINES; CRITICAL CARE; CRITICAL ILLNESS; ENTEROCYTES; EPINEPHRINE; FATTY ACID-BINDING PROTEINS; FEMALE; HEMODYNAMICS; HUMANS; INTENSIVE CARE UNITS; INTESTINE, SMALL; MALE; MIDDLE AGED; NOREPINEPHRINE; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 84928641525     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000327     Document Type: Article

References (27)

1. Reintam A, Parm P, Kitus R, Kern H, Starkopf J: Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand 53(3):318-324, 2009.
2. Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G: Acute intestinal failure in critically ill patients: is plasma citrulline the right marker Intensive Care Med 37(6):911-917, 2011.
3. Piton G, Belon F, Cypriani B, Regnard J, Puyraveau M, Manzon C, Navellou JC, Capellier G: Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Crit Care Med 41(9):2169-2176, 2013.
4. Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110(2):339-343, 1996.
5. Kanda T, Tsukahara A, Ueki K, Sakai Y, Tani T, Nishimura A, Yamazaki T, Tamiya Y, Tada T, Hirota M, et al.: Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol 46(4):492-500, 2011.
6. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25(3): 399-404, 1997.
7. Sautner T, Wessely C, Riegler M, Sedivy R, Götzinger P, Losert U, Roth E, Jakesz R, Függer R: Early effects of catecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxin shock. Ann Surg 228(2):239-248, 1998.
8. Malbrain MLNG, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, et al.: Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med 32(11):1722-1732, 2006.
9. Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L: Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem 43(8 Pt 1):1421-1428, 1997.
10. Thuijls G, van Wijck K, Grootjans J, Derikx JPM, van Bijnen AA, Heineman E, Dejong CH, Buurman WA, Poeze M: Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg 253(2):303-308, 2011.
11. Vincent JL, Moreno R, Takala J, Willatts S, De Mendoncą A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707-710, 1996.
12. Wang TY, Liu M, Portincasa P, Wang DQ-H: New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Invest 43(11):1203-1223, 2013.
13. Matsumoto S, Sekine K, Funaoka H, Yamazaki M, Shimizu M, Hayashida K, Kitano M: Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia. Br J Surg 101(3):232-238, 2014.
14. Güzel M, Sözuër EM, Salt O, Ikizceli I, Akdur O, Yazc C: The value of the serum I-FABP level for diagnosing acute mesenteric ischemia. Surg Today 44(11):2072-2076, 2014.
15. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101(4):478-483, 1970.
16. Schellekens DHSM, Grootjans J, Dello SAWG, van Bijnen AA, van Dam RM, Dejong CHC, Derikx JP, BuurmanWA: Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J Clin Gastroenterol 48(3):253-260, 2014.
17. De Backer D, Creteur J, Silva E, Vincent J-L: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best Crit Care Med 31(6):1659-1667, 2003.
18. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K: Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27(5):893-900, 1999.
19. Benbenishty J, Weissman C, Sprung CL, Brodsky-Israeli M, Weiss Y: Characteristics of patients receiving vasopressors. Heart Lung J Crit Care 40(3): 247-252, 2011.
20. Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216(2):117-134, 1992.
21. Björck M, Wanhainen A: Nonocclusive mesenteric hypoperfusion syndromes: recognition and treatment. Semin Vasc Surg 23(1):54-64, 2010.
22. Kolkman JJ, Mensink PBF: Non-occlusive mesenteric ischaemia: a common disorder in gastroenterology and intensive care. Best Pract Res Clin Gastroenterol 17(3):457-473, 2003.
23. Lobo SM, De Backer D, Sun Q, Tu Z, Dimopoulos G, Preiser J-C, Nagy N, Vray B, Vercruy V, Terzi RG, et al.: Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemia. J Appl Physiol 95(5):2047-2054, 2003.
24. Hietbrink F, Besselink MGH, Renooij W, de Smet MBM, Draisma A, van der Hoeven H, Pickkers P: Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock 32(4):374-378, 2009.
25. Mancl EE, Muzevich KM: Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy. JPEN J Parenter Enteral Nutr 37(5):641-651, 2013.
26. De Backer D, Ortiz JA, Salgado D: Coupling microcirculation to systemic hemodynamics. Curr Opin Crit Care 16(3):250-254, 2010.
27. Thuijls G, Derikx JPM, de Kruijf M, van Waardenburg DA, van Bijnen AA, Ambergen T, van Rhijn LW, Willigers HM, Buurman WA: Preventing enterocyte damage by maintenance of mean arterial pressure during major nonabdominal surgery in children. Shock 37(1):22-27, 2012.